Covid-19 vaccines: authorised
14. Oktober 2022 – The European Commission issued a decision renewing the conditional marketing authorisation for Nuvaxovid.
For more information, see here.
14. Oktober 2022 – The European Commission issued a decision renewing the conditional marketing authorisation for Nuvaxovid.
For more information, see here.